SEC Stock Data Quick Answer ALX ONCOLOGY HOLDINGS INC reported Total Assets of $59.05 million for fiscal year 2025. ALX ONCOLOGY HOLDINGS INC Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $59.05M -60.0% 2024 $147.78M -39.1% 2023 $242.55M -20.9% 2022 $306.49M -19.4% 2021 $380.18M -12.8% 2020 $436.05M +3984.4% 2019 $10.68M — Quarterly Total Assets … Read more
Quick Answer ALX ONCOLOGY HOLDINGS INC reported Diluted EPS of $1.90 per share (loss) for fiscal year 2025. ALX ONCOLOGY HOLDINGS INC Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$1.90 +26.4% 2024 -$2.58 +31.0% 2023 -$3.74 -23.4% 2022 -$3.03 -46.4% 2021 -$2.07 — Quarterly Diluted EPS Quarter Ending Diluted EPS … Read more
Quick Answer ALX ONCOLOGY HOLDINGS INC reported Net Income of -$101.69 million for fiscal year 2025. ALX ONCOLOGY HOLDINGS INC Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$101.69M +24.6% 2024 -$134.85M +16.1% 2023 -$160.81M -30.2% 2022 -$123.48M -47.9% 2021 -$83.46M -82.5% 2020 -$45.74M -137.7% 2019 -$19.24M -40.1% 2018 -$13.73M — … Read more
Quick Answer ALX ONCOLOGY HOLDINGS INC reported Revenue (ASC 606) of $0.00 for fiscal year 2022. ALX ONCOLOGY HOLDINGS INC Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2022 $0.00 — 2021 $0.00 -100.0% 2020 $1.18M -75.4% 2019 $4.80M +132.0% 2018 $2.07M — Quarterly Revenue (ASC 606) Quarter Ending Revenue … Read more
Quick Answer ALX ONCOLOGY HOLDINGS INC reported Total Revenue of $0.00 for fiscal year 2022. ALX ONCOLOGY HOLDINGS INC Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2022 $0.00 — 2021 $0.00 -100.0% 2020 $1.18M -75.4% 2019 $4.80M +132.0% 2018 $2.07M — Quarterly Total Revenue Quarter Ending Total Revenue YoY QoQ June … Read more
Quick Answer ALX ONCOLOGY HOLDINGS INC reported Total Revenue of $0.00 for fiscal year 2022. ALX ONCOLOGY HOLDINGS INC — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue — — — $0.00 $0.00-100.0% $1.18M-75.4% Revenue (ASC 606) — — — $0.00 $0.00-100.0% $1.18M-75.4% Net Income -$101.69M+24.6% -$134.85M+16.1% -$160.81M-30.2% -$123.48M-47.9% -$83.46M-82.5% … Read more
Quick Answer ALEXANDERS INC reported Shares Outstanding of 5.11 million shares for fiscal year 2025. ALEXANDERS INC Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 5.11M +0.0% 2024 5.11M +0.0% 2023 5.11M +0.0% 2022 5.11M +0.0% 2021 5.11M +0.0% 2020 5.11M +0.0% 2019 5.11M +0.0% 2018 5.11M +0.0% 2017 5.11M +0.0% … Read more
Quick Answer ALEXANDERS INC reported Operating Income of $100.62 million for fiscal year 2018. ALEXANDERS INC Operating Income — Annual History Fiscal Year Operating Income YoY Change 2018 $100.62M -4.4% 2017 $105.27M -0.2% 2016 $105.46M +10.8% 2015 $95.20M -1.5% 2014 $96.69M -0.8% 2013 $97.52M +2.0% 2012 $95.58M -2.2% 2011 $97.69M +7.4% 2010 $90.99M -39.8% 2009 … Read more
Quick Answer ALEXANDERS INC reported Stockholders Equity of $109.16 million for fiscal year 2025. ALEXANDERS INC Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $109.16M -38.3% 2024 $176.86M -25.6% 2023 $237.66M +0.5% 2022 $236.50M -6.4% 2021 $252.59M +24.3% 2020 $203.23M -19.8% 2019 $253.51M -11.1% 2018 $285.09M -17.1% 2017 $343.95M -2.5% 2016 … Read more
Quick Answer ALEXANDERS INC reported Cash and Equivalents of $128.17 million for fiscal year 2025. ALEXANDERS INC Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $128.17M -62.1% 2024 $338.53M -36.3% 2023 $531.86M +172.8% 2022 $194.93M -57.9% 2021 $463.54M +8.1% 2020 $428.71M +43.8% 2019 $298.06M +5.3% 2018 $283.06M -8.0% 2017 … Read more